Wei Xiao

This inventor holds 21 USPTO granted patents and 8 published patent applications and 9 EPO patents, primarily in Traditional Chinese Medicine. Top assignees: Jiangsu Kanion Pharmaceutical Co., Ltd., Jiangsu Kanion Pharmaceutical Co., Ltd., Jiangsu Kanion Pharmaceuticals, Co. Ltd.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Xiao. Retrieved from https://idiyas.com/inventor/wei-xiao-7m64v9ua

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 8)

% Patents Active = 100.0

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Jiangsu, JP (2018)
Jiangsu, CN (2003 - 2023)
Lianyungang, CN (2012 - 2024)

Company Filing History:

17 out of 18

Jiangsu Kanion Pharmaceutical Co., Ltd.

patents

2 out of 7

Jiangsu Kanion Pharmaceutical Co., Ltd.

patents

1 out of 1

Jiangsu Kanion Pharmaceuticals, Co. Ltd.

patent

4. 1 out of 4

Newgen Therapeutics, Inc.

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Traditional Chinese Medicine

Anti-Arrhythmic

Coronavirus Treatment

Gingko Diterpene

Emodin Succinyl Ester

Herbal Composition

Cinnamomi

Pharmaceutical Composition

Thiadiazolidine

Quinazoline Compounds

Chronic Renal Failure

Preparation Method

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691155 - Traditional Chinese medicine composition, and preparation method therefor and use thereof (2026-07-28),

2. 12622902 - Anti-arrhythmic pharmaceutical composition and preparation method therefor (2026-05-12),

3. 12558394 - Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection (2026-02-24),

4. 12497463 - ANTI-CD38 ANTIBODY AND USE THEREOF (2025-12-16),

5. 12409192 - Traditional Chinese medicine composition and use thereof (2025-09-09),

6. 11958860 - Crystal form of compound, and preparation method therefor and use thereof (2024-04-16),

7. 11814352 - Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof (2023-11-14),

8. 11576942 - Traditional Chinese medicine composition and preparation method and application thereof (2023-02-14),

9. 11564904 - Gingko diterpene lactone composition (2023-01-31),

10. 11524041 - Ginkgo diterpene lactone composition (2022-12-13),

11. 11254635 - Emodin succinyl ester compound, preparation method therefor and application thereof (2022-02-22),

12. 10227339 - Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate (2019-03-12),

13. 9988361 - Anti-enterovirus 71 thiadiazolidine derivative (2018-06-05),

14. 9187459 - Quinazoline-7-ether compounds and methods of use (2015-11-17),

15. 8119141 - Cinnamomi and poria composition, method to prepare same and uses thereof (2012-02-21),

Title: Wei Xiao: Innovator in Traditional Chinese Medicine

Introduction

Wei Xiao is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of traditional Chinese medicine. With a total of 17 patents to his name, he has made remarkable advancements that blend ancient practices with modern scientific approaches.

Latest Patents

Among his latest patents is a traditional Chinese medicine composition that includes active ingredients derived from various natural sources. This composition is designed to provide antipyretic, anti-inflammatory, and antitussive effects. Another notable patent is for a crystal form A of a compound, which boasts high stability and low hygroscopicity, making it suitable for patent medicine. The X-ray powder diffraction pattern of this crystal form includes specific 2θ values, ensuring its unique properties.

Career Highlights

Wei Xiao has worked with reputable companies such as Jiangsu Kanion Pharmaceutical Co., Ltd. and Newgen Therapeutics, Inc. His work in these organizations has allowed him to further develop his innovative ideas and contribute to the pharmaceutical industry.

Collaborations

Throughout his career, Wei Xiao has collaborated with notable individuals, including Zhenzhong Wang and Wang Shen. These partnerships have facilitated the exchange of ideas and fostered advancements in their respective fields.

Conclusion

Wei Xiao's dedication to innovation in traditional Chinese medicine has led to significant advancements that benefit both the industry and patients. His work exemplifies the fusion of tradition and modern science, paving the way for future developments in healthcare.

Profile summary based on public USPTO records.